Vascular ageing: moving from bench towards bedside

RE Climie, J Alastruey, CC Mayer… - European journal of …, 2023 - academic.oup.com
Prevention of cardiovascular disease (CVD) remains one of the largest public health
challenges of our time. Identifying individuals at increased cardiovascular risk at an …

[HTML][HTML] Arterial stiffness in the heart disease of CKD

L Zanoli, P Lentini, M Briet, P Castellino… - Journal of the …, 2019 - journals.lww.com
CKD frequently leads to chronic cardiac dysfunction. This complex relationship has been
termed as cardiorenal syndrome type 4 or cardio-renal link. Despite numerous studies and …

Targeting vascular calcification in chronic kidney disease

AJ Nelson, P Raggi, M Wolf, AM Gold… - Basic to Translational …, 2020 - jacc.org
Cardiovascular (CV) disease remains an important cause of morbidity and mortality for
patients with chronic kidney disease (CKD). Although clustering of traditional risk factors with …

Cellular senescence contributes to large elastic artery stiffening and endothelial dysfunction with aging: amelioration with senolytic treatment

ZS Clayton, MJ Rossman, SA Mahoney… - …, 2023 - Am Heart Assoc
BACKGROUND: Here, we assessed the role of cellular senescence and the senescence
associated secretory phenotype (SASP) in age-related aortic stiffening and endothelial …

[HTML][HTML] Chronic kidney disease and arterial stiffness: a two-way path

F Inserra, P Forcada, A Castellaro… - Frontiers in Medicine, 2021 - frontiersin.org
The kidney-heart relationship has raised interest for the medical population since its vast
and complex interaction significantly impacts health. Chronic kidney disease (CKD) …

State of the art review: brachial-ankle PWV

H Tomiyama, K Shiina - Journal of atherosclerosis and thrombosis, 2020 - jstage.jst.go.jp
First, we would like to briefly describe the changes in the arterial medial layer that occur in
association with atherosclerotic vascular damage, affecting the arterial stiffness5-8). The …

Systemic hemodynamic atherothrombotic syndrome (SHATS)–coupling vascular disease and blood pressure variability: proposed concept from Pulse of Asia

K Kario, JA Chirinos, RR Townsend, MA Weber… - Progress in …, 2020 - Elsevier
Hypertension (HTN) is an important risk factor for cardiovascular disease (CVD) but the
association between HTN and CVD cannot be explained by average blood pressure (BP) …

[HTML][HTML] Accelerated AGEing: The impact of advanced glycation end products on the prognosis of chronic kidney disease

E Dozio, L Caldiroli, P Molinari, G Castellano… - Antioxidants, 2023 - mdpi.com
Advanced glycation end products (AGEs) are aging products. In chronic kidney disease
(CKD), AGEs accumulate due to the increased production, reduced excretion, and the …

Association of arterial stiffness with chronic kidney disease progression and mortality

JG Voicehovska, E Bormane, A Grigane… - Heart, Lung and …, 2021 - Elsevier
Chronic kidney disease (CKD) is a major public health concern. Despite many potentially life-
threatening conditions that can accompany kidney disease, cardiovascular disease (CVD) …

The effect of exercise on vascular health in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials

MD Davies, F Hughes, A Sandoo… - American Journal …, 2023 - journals.physiology.org
Patients with chronic kidney disease (CKD) are at increased risk of cardiovascular disease.
This increased risk cannot be fully explained by traditional risk factors such as hypertension …